SEQUENT.NS Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 bal. 2024 @ 13:00):

Stats
Šios dienos apimtis	667 542
Vidutinė apimtis	1.59M
Rinkos kapitalizacija	31.15B
EPS	INR0 ( 2024-02-13 )
Kita pelno data	( INR0 ) 2024-05-20
Last Dividend	INR0.500 ( 2021-09-08 )
Next Dividend	INR0 ( N/A )
P/E	-24.07
ATR14	INR0.170 (0.14%)

Tūris Koreliacija

Ilgas: 0.54 (weak)

Trumpas: -0.83 (strong negative)

Signal:(41.021) Neutral

Sequent Scientific Koreliacija

10 Labiausiai teigiamai susiję koreliacijos

10 Labiausiai neigiamai susiję koreliacijos

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Sequent Scientific Koreliacija - Valiuta/Žaliavos

-0.13
( neutral )

-0.39
( neutral )

0.00
( neutral )

-0.09
( neutral )

-0.12
( neutral )

-0.32
( neutral )

Sequent Scientific Finansinės ataskaitos

Annual	2022
Pajamos:	INR14.21B
Bruto pelnas:	INR5.87B (41.32 %)
EPS:	INR-4.88

FY	2022
Pajamos:	INR14.21B
Bruto pelnas:	INR5.87B (41.32 %)
EPS:	INR-4.88

FY	2022
Pajamos:	INR14.10B
Bruto pelnas:	INR5.66B (40.12 %)
EPS:	INR1.670

FY	2021
Pajamos:	INR13.62B
Bruto pelnas:	INR6.25B (45.91 %)
EPS:	INR3.87

Financial Reports:

No articles found.

Sequent Scientific Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)

Sequent Scientific Dividend Information - No Dividend Player

Dividend Sustainability Score: 0 - low (50.00%) | Divividend Growth Potential Score: 1.087 - No dividend growth expected in the near future

Information

First Dividend	INR0.200	2017-11-20
Last Dividend	INR0.500	2021-09-08
Next Dividend	INR0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	3	--
Total Paid Out	INR0.900	--
Avg. Dividend % Per Year	0.04%	--
Score	0.38	--
Div. Sustainability Score	0
Div.Growth Potential Score	1.087
Div. Directional Score	0.450	--

Next Divdend (Est)
(2025-03-10)

INR0 Estimate 0.00 %

Dividend Stability

0.02 Very Bad

Dividend Score

0.38

Pay Frequency

Sporadic

Yearly Payout

Year	Amount	Yield
2017	INR0	0.00%
2018	INR0	0.00%
2019	INR0.200	0.30%
2020	INR0	0.00%
2021	INR0.500	0.29%
2022	INR0	0.00%
2023	INR0	0.00%
2024	INR0	0.00%

Dividend Commentary

The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Considering all factors, the near-term dividend outlook for the company remains unpromising.

Top 10 dividend Companies for NSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
TINPLATE.NS	Dividend Junior	2023-08-11	Annually	19	0.72%
PDMJEPAPER.NS	Dividend Junior	2023-08-03	Annually	9	0.65%
J&KBANK.NS	Dividend Junior	2023-08-17	Sporadic	22	0.47%
DATAMATICS.NS	Dividend Junior	2023-09-22	Annually	21	0.49%
SHYAMMETL.NS	Dividend Junior	2023-06-05	Semi-Annually	4	0.70%
MAXHEALTH.NS	Dividend Junior	2023-09-08	Insufficient data to determine frequency	2	0.07%
GSPL.NS	Dividend Junior	2023-09-01	Annually	19	0.81%
BANKINDIA.NS	Dividend Junior	2023-06-20	Sporadic	23	1.34%
PRAJIND.NS	Dividend Junior	2023-07-19	Annually	22	0.83%
KABRAEXTRU.NS	Dividend Junior	2023-07-13	Annually	23	0.83%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	-0.0935	1.500	-1.869	-2.80	[0 - 0.5]
returnOnAssetsTTM	0	1.200	0	0	[0 - 0.3]
returnOnEquityTTM	-0.186	1.500	-3.18	-4.77	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0	0.800	-5.00	-4.00	[1 - 3]
quickRatioTTM	0	0.800	-4.71	-3.76	[0.8 - 2.5]
cashRatioTTM	0	1.500	-1.111	-1.667	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	-1.024	1.000	-1.490	-1.490	[3 - 30]
operatingCashFlowPerShareTTM	3.93	2.00	8.69	10.00	[0 - 30]
freeCashFlowPerShareTTM	3.93	2.00	8.03	10.00	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0.374	1.000	7.09	7.09	[0.2 - 0.8]
operatingProfitMarginTTM	-0.0346	1.000	-2.69	-2.69	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0	0.800	-3.33	-2.67	[0.5 - 2]
Total Score				-0.187

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-24.14	1.000	-2.54	0	[1 - 100]
returnOnEquityTTM	-0.186	2.50	-2.04	-4.77	[0.1 - 1.5]
freeCashFlowPerShareTTM	3.93	2.00	8.69	10.00	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	3.93	2.00	8.69	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0.425	1.500	-0.502	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0711	1.000	-0.723	0	[0.1 - 0.5]
Total Score				1.087

Sequent Scientific

Sequent Scientific Limited engages in the animal health business worldwide. The company provides animal health active pharmaceutical ingredients (APIs) and finished dosage formulations in the areas of feed supplements, antibiotics, anthelmintics, antibacterial, anti-protozoal, nutraceuticals, nonsteroidal anti-inflammatory drugs, anti-infectives, and dermatology. It offers analytical solutions that supports API, pharmaceutical, personal care, and nutraceutical organizations, as well as provides method validation, stability, and microbiology for APIs and finished products. The company was formerly known as PI Drugs and Pharmaceuticals Limited and changed its name to Sequent Scientific Limited in October 2009. Sequent Scientific Limited was incorporated in 1985 and is headquartered in Mumbai, India. Sequent Scientific Limited operates as a subsidiary of CA Harbor Investments.